| Source of Funding | FY 2009 Actual | FY 2010 Estimate | FY 2011 PB |
|---|---|---|---|
|
Appropriation
|
$1,080,796,000
|
$1,110,229,000
|
$1,142,337,000
|
|
Type 1 Diabetes
|
0
|
0
|
0
|
|
Rescission
|
0
|
0
|
0
|
|
Supplemental
|
0
|
0
|
0
|
|
Subtotal, adjusted appropriation
|
1,080,796,000
|
1,110,229,000
|
1,142,337,000
|
|
Real transfer under Director's one-percent transfer authority (GEI)
|
-1,792,000
|
0
|
0
|
|
Comparative transfer to NLM for NCBI assessment
|
-171,000
|
-264,000
|
0
|
|
Comparative transfer to NLM for Public Access assessment
|
-153,000
|
-165,000
|
0
|
|
Comparative transfer under Director's one-percent transfer authority (GEI)
|
1,792,000
|
0
|
0
|
|
Unobligated balance, start of year
|
0
|
0
|
0
|
|
Unobligated balance, end of year
|
0
|
0
|
0
|
|
Subtotal, adjusted budget authority
|
1,080,472,000
|
1,109,800,000
|
1,142,337,000
|
|
Unobligated balance lapsing
|
0
|
0
|
0
|
|
Total obligations
|
1,080,472,000
|
1,109,800,000
|
1,142,337,000
|
Excludes the following amounts for reimbursable activities carried out by this account: FY 2009 - $8,278,000 FY 2010 - $8,278,000 FY 2011 - $8,278,000 Excludes $15,882,000 Actual in FY 2009; Estimate $16,000,000 in FY 2010 and Estimate $16,200,000 in FY 2011 for royalties.
